Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy - Related Studies

Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

This study is ongoing, but not recruiting participants.

Study NCT00004001. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Prostate Cancer

2	Additional conditions recognized in this trial
		Prostatic Neoplasms

3	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		docetaxel
		estramustine phosphate sodium
		mitoxantrone hydrochloride
		prednisone

5	Additional drug interventions recognized in this trial
		Estramustine
		Mitoxantrone

6	More general drug interventions related to this trial
		Alkylating Agents
		Analgesics
		Anti-Inflammatory Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Central Nervous System Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Southwest Oncology Group
		National Cancer Institute (NCI)
		Cancer and Leukemia Group B
		North Central Cancer Treatment Group